QCL-105768 (015K-CL-PK15)

• Research type

  Research Study

• Full title

  A regional drug absorption study to assess the bioavailability of ASP015K in healthy subjects

• IRAS ID

  57166

• Contact name

  Philip Evans

• Sponsor organisation

  Astellas Pharma Global Development, Inc.

• Eudract number

  2010-021160-15

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• Research summary

  ASP015K is being developed as a potential immunosuppressant for use in human organ transplants and treatment of immune system-related diseases. This study will assess and compare how well ASP015K is absorbed into the bloodstream when it is released either in the stomach or in 3 other targeted regions in the gut.

• REC name

  South Central - Berkshire B Research Ethics Committee

• REC reference

  10/IEC04/17

• Date of REC Opinion

  9 Aug 2010

• REC opinion

  Further Information Favourable Opinion